Catheter Precision (VTAK) Amortization of Deferred Charges (2019 - 2025)

Catheter Precision (VTAK) reported Amortization of Deferred Charges of $18000.0 for Q4 2025, up 5.88% quarter-over-quarter from $17000.0 in Q3 2025.

Catheter Precision (VTAK) Amortization of Deferred Charges (2019 - 2025) Analysis & Trends

Catheter Precision (VTAK) has 3 years of Amortization of Deferred Charges data on file, last reported at $18000.0 in Q4 2025.

Amortization of Deferred Charges for Q4 2025 came in at $18000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $35000.0 (down 82.5% YoY), and the FY2025 annual result was $45000.0, changed N/A from the prior year.
Amortization of Deferred Charges grew to $18000.0 in Q4 2025 per VTAK's latest filing, from $17000.0 in the prior quarter.
Over five years, Amortization of Deferred Charges peaked at $18000.0 in Q4 2025 and troughed at $17000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn
10	Catheter Precision	1.19 Mn	381,424.70	390,000.00

Download Data